Two Sigma Investments’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $948K | Buy |
72,144
+56,844
| +372% | +$747K | ﹤0.01% | 2242 |
|
2025
Q1 | $220K | Sell |
15,300
-22,600
| -60% | -$325K | ﹤0.01% | 2765 |
|
2024
Q4 | $635K | Sell |
37,900
-66,008
| -64% | -$1.11M | ﹤0.01% | 2359 |
|
2024
Q3 | $1.66M | Buy |
103,908
+52,108
| +101% | +$833K | ﹤0.01% | 1730 |
|
2024
Q2 | $468K | Sell |
51,800
-26,981
| -34% | -$244K | ﹤0.01% | 2329 |
|
2024
Q1 | $890K | Buy |
78,781
+62,281
| +377% | +$704K | ﹤0.01% | 1963 |
|
2023
Q4 | $131K | Buy |
16,500
+4,900
| +42% | +$39K | ﹤0.01% | 2827 |
|
2023
Q3 | $75.1K | Buy |
11,600
+500
| +5% | +$3.24K | ﹤0.01% | 2695 |
|
2023
Q2 | $68.7K | Buy |
+11,100
| New | +$68.7K | ﹤0.01% | 2714 |
|
2021
Q3 | – | Sell |
-9,973
| Closed | -$222K | – | 2578 |
|
2021
Q2 | $222K | Buy |
+9,973
| New | +$222K | ﹤0.01% | 2200 |
|